Essential thrombocythemia treatment algorithm 2018.

Item

http://www.wikidata.org/entity/Q47565721

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Essential thrombocythemia treatment algorithm 2018.

@en

Essential thrombocythemia treatment algorithm 2018.

@nl

type

Item

label

Essential thrombocythemia treatment algorithm 2018.

@en

Essential thrombocythemia treatment algorithm 2018.

@nl

prefLabel

Essential thrombocythemia treatment algorithm 2018.

@en

Essential thrombocythemia treatment algorithm 2018.

@nl

P1476

Essential thrombocythemia treatment algorithm 2018.

@en

P2093

Alessandro M Vannucchi

http://www.w3.org/2001/XMLSchema#string

Tiziano Barbui

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.

Long-term use of anagrelide in young patients with essential thrombocythemia.

Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia.

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.

Essential thrombocythemia and pregnancy.

P2888

s41408-017-0041-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1038/S41408-017-0041-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayalew Tefferi

P5008

ScienceSource

P577

2018-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29321520

http://www.w3.org/2001/XMLSchema#string

P921

Essential thrombocytosis

P932

5802626

http://www.w3.org/2001/XMLSchema#string